Medi-Tech Insights

The IVD market is the area of the healthcare sector that deals with diagnostic testing performed on extra-body samples, such as blood, urine, tissue, and more. These tests are essential for diagnosing illnesses, keeping an eye on medical problems, and directing treatment choices. They are usually carried out in a laboratory environment. The IVD market includes a broad spectrum of diagnostic devices and technologies, such as: Clinical Chemistry: Tests measuring levels of substances in bodily fluids like blood and urine, such as glucose, cholesterol, and electrolytes Immunoassays: Tests detecting specific proteins, hormones, or antibodies in the blood or other bodily fluids, often used in diagnosing infections, autoimmune disorders, and cancer. Molecular Diagnostics: Techniques detecting genetic material (DNA or RNA) to diagnose genetic disorders, infectious diseases, and cancer, among others Point-of-Care Testing ( POCT ): Rapid diagnostic tests performed near the patient, outside of t...

  Key growth factors for the IORT market include an increased need for precise and targeted cancer treatments, rapid technological advancements that enhance treatment efficacy and safety, and supportive regulatory frameworks that allow for market expansion. Furthermore, the rising global incidence of cancer, along with efforts to reduce treatment periods and improve patient outcomes, is propelling the development of IORT as a feasible oncological therapy. Interoperative radiation therapy (IORT) is a cancer treatment method that is usually used with surgery. It comprises providing a single, high-dose radiation therapy to a tumor site during surgery, just after the tumor has been removed. This is often performed with the use of a bespoke radiation delivery device. The advantage of IORT is that it allows for precise radiation targeting of the tumor bed while sparing healthy tissues surrounding it. Radiation given directly to the tumor site during surgery may help reduce the risk of c...